Evonik Industries has launched the Medical Devices Project House early in April in Birmingham, Alabama, the US, along with a branch in Hanau, Germany.

Dr Peter Nagler, Chief Innovation Officer at Evonik, says, "In the new Medical Devices Project House, we are pooling and expanding the interdisciplinary competencies of Evonik in the area of medical technology and biomaterial research. By locating it in the US, we are continuing to internationalize our R&D activities."

The global medical technology market with a volume of 300 billion euro is posting annual growth rates of 6%, according to statistics quoted in Evonik's statement. At 40%, the US accounts for a major proportion of this world market and US companies hold leading positions, above all in the area of implantology.

"Our location in Birmingham places our research at the center of the highly attractive US market with great proximity to our customers. At the same time, we benefit from the expertise of the Health Care Business Line of Evonik, which manages the site in Birmingham," explains Dr Rosario Lizio, who heads the Medical Devices Project House.

In the project houses, Creavis, the strategic innovation unit of Evonik, works together with several business units on a defined topic area.

Including the Medical Devices Project House, three Evonik project houses are currently active: The Light & Electronics Project House in Taiwan is researching new technologies and products for the display, LED, and lighting industry, and the Composites Project House in Marl is dealing with new materials and system solutions for the lightweight construction sector.

Evonik Industries has launched the Medical Devices Project House early in April in Birmingham, Alabama, the US, along with a branch in Hanau, Germany.

Dr Peter Nagler, Chief Innovation Officer at Evonik, says, "In the new Medical Devices Project House, we are pooling and expanding the interdisciplinary competencies of Evonik in the area of medical technology and biomaterial research. By locating it in the US, we are continuing to internationalize our R&D activities."

The global medical technology market with a volume of 300 billion euro is posting annual growth rates of 6%, according to statistics quoted in Evonik's statement. At 40%, the US accounts for a major proportion of this world market and US companies hold leading positions, above all in the area of implantology.

"Our location in Birmingham places our research at the center of the highly attractive US market with great proximity to our customers. At the same time, we benefit from the expertise of the Health Care Business Line of Evonik, which manages the site in Birmingham," explains Dr Rosario Lizio, who heads the Medical Devices Project House.

In the project houses, Creavis, the strategic innovation unit of Evonik, works together with several business units on a defined topic area.

Including the Medical Devices Project House, three Evonik project houses are currently active: The Light & Electronics Project House in Taiwan is researching new technologies and products for the display, LED, and lighting industry, and the Composites Project House in Marl is dealing with new materials and system solutions for the lightweight construction sector.